Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2026-01-21 @ 12:31 PM
Study NCT ID:
NCT05942768
Status:
COMPLETED
Last Update Posted:
2023-07-12
First Post:
2023-07-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
Sponsor:
Hunan Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2023-07-04
First Submit QC Date:
None
Study First Post Date:
2023-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-04
Last Update Post Date:
2023-07-12
Last Update Post Date Type:
ACTUAL